20
Participants
Start Date
January 1, 2026
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Mixed reality (XR) Exposure Therapy
Participants will engage in a minimum 8-session intervention combining Cognitive Behavioral Therapy (CBT) and Extended Reality Therapy (XRET) to address needle phobia and blood-injection-injury (BII) phobia. The intervention begins with an initial intake session where the APA-SMS screener results are reviewed. Participants will then undergo VR exposure, with mixed exposure to sham needles in the latter exposure session. Anxiety levels will be assessed using a Visual Analog Scale (VAS-A) during and after each session. If fail to achieve the desired anxiety score, participants will continue working with the study team until ready to progress. The final session includes in-person exposure to a real needle, aiming for voluntary vaccination or IV placement. Coping strategies will be discussed at the final session. Participants will be contacted for follow-up assessments at 6 and 12 weeks to evaluate long-term outcomes.
Lucile Parkard Children's Hospital, Stanford
Stanford University
OTHER